MBIO
Price:
$0.5969
Market Cap:
$4.52M
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating cell therapies into cures for difficult-to-treat cancers and autoimmune diseases in the United States. The company develops MB-106, a CD20-targeted chimeric antigen receptor (CAR) T cell therapy which is in Phase I clinical trail for non-hodgkin lymphoma, chronic lymphocytic leukemia, and autoimmune diseases; MB-109, a combination MB-101 and MB-108 as a potential treatment for IL13Ra2+ relapsed or refractory glioblastoma and high-grade astrocytoma; MB-101, an IL13Ra2 CAR T cell program completd Phase I for glioblastoma; and MB-108 which is in Phase I for the treatment of herpes simplex virus-1 oncolytic vir...[Read more]
Industry
Biotechnology
IPO Date
2017-08-22
Stock Exchange
NASDAQ
Ticker
MBIO
According to Mustang Bio, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -1.24. This represents a change of -54.04% compared to the average of -2.70 of the last 4 quarters.
The mean historical PE Ratio of Mustang Bio, Inc. over the last ten years is -209.99. The current -1.24 PE Ratio has changed -40.95% with respect to the historical average. Over the past ten years (40 quarters), MBIO's PE Ratio was at its highest in in the June 2026 quarter at -1.10. The PE Ratio was at its lowest in in the September 2016 quarter at -1717.29.
Average
-209.99
Median
-119.19
Minimum
-1015.19
Maximum
-2.52
Discovering the peaks and valleys of Mustang Bio, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 18.27%
Maximum Annual PE Ratio = -2.52
Minimum Annual Increase = -75.89%
Minimum Annual PE Ratio = -1015.19
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -2.52 | -26.95% |
| 2024 | -3.44 | -69.39% |
| 2023 | -11.25 | -57.27% |
| 2022 | -26.33 | -75.89% |
| 2021 | -109.21 | -34.21% |
| 2020 | -166.01 | 8.67% |
| 2019 | -152.77 | 18.27% |
| 2018 | -129.17 | -73.31% |
| 2017 | -483.99 | -52.33% |
| 2016 | -1015.19 | -7.46% |
The current PE Ratio of Mustang Bio, Inc. (MBIO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-5.74
5-year avg
-30.55
10-year avg
-209.99
Mustang Bio, Inc.’s PE Ratio is greater than Marker Therapeutics, Inc. (-1.70), less than Bolt Biotherapeutics, Inc. (-0.25), less than TransCode Therapeutics, Inc. (-0.09), less than Lyra Therapeutics, Inc. (-0.02), less than Acurx Pharmaceuticals, Inc. (-0.30), less than Evogene Ltd. (-0.46), less than Dogwood Therapeutics, Inc. (-0.17), less than Abpro Corporation (0.26), greater than Immuron Limited (-1.71), less than Traws Pharma, Inc. (-0.64),
| Company | PE Ratio | Market cap |
|---|---|---|
| -1.70 | $12.31M | |
| -0.25 | $7.59M | |
| -0.09 | $4.50M | |
| -0.02 | $709.95K | |
| -0.30 | $2.33M | |
| -0.46 | $5.44M | |
| -0.17 | $3.50M | |
| 0.26 | $1.06M | |
| -1.71 | $7.09M | |
| -0.64 | $5.06M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Mustang Bio, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Mustang Bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Mustang Bio, Inc.'s PE Ratio?
How is the PE Ratio calculated for Mustang Bio, Inc. (MBIO)?
What is the highest PE Ratio for Mustang Bio, Inc. (MBIO)?
What is the 3-year average PE Ratio for Mustang Bio, Inc. (MBIO)?
What is the 5-year average PE Ratio for Mustang Bio, Inc. (MBIO)?
How does the current PE Ratio for Mustang Bio, Inc. (MBIO) compare to its historical average?